ARID4B and type 2 diabetes mellitus: Our results on the BCAA degradation pathway are also consistent with several previous reports on ScWAT [41, 56–58], as well as lower levels of some transcripts related to BCAA degradation in SkM from patients with type 2 diabetes [59].